Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions
Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun
Clin Mol Hepatol. 2023;29(2):465-481. Published online 2023 Feb 20 DOI: https://doi.org/10.3350/cmh.2022.0327
|
Citations to this article as recorded by
Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid
Kang Wu, Yi Liu, Jie Xia, Jiale Liu, Kai Wang, Huijun Liang, Fengli Xu, Dina Liu, Dan Nie, Xin Tang, Ailong Huang, Chang Chen, Ni Tang
Advanced Science.2024;[Epub] CrossRef Collaborative Metabolism: Gut Microbes Play a Key Role in Canine and Feline Bile Acid Metabolism
John C. Rowe, Jenessa A. Winston
Veterinary Sciences.2024; 11(2): 94. CrossRef Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence
Zhu Liang, Keyan Zhang, Hongli Guo, Xujiao Tang, Mingzhu Chen, Jinsong Shi, Jing Yang
International Immunopharmacology.2024; 132: 111981. CrossRef S1PR2 participates in intestinal injury in severe acute pancreatitis by regulating macrophage pyroptosis
Tianjiao Lin, Mengyuan Peng, Qingyun Zhu, Xinting Pan
Frontiers in Immunology.2024;[Epub] CrossRef Microglia-mediated pericytes migration and fibroblast transition via S1P/S1P3/YAP signaling pathway after spinal cord injury
Ziyuan Yu, Huabin Zhang, Linxi Li, Zhi Li, Danmin Chen, Xiao Pang, Yunxiang Ji, Yezhong Wang
Experimental Neurology.2024; 379: 114864. CrossRef Human placental mesenchymal stromal cells promote the formation of CD8+CD122+PD-1+Tregs via CD73/Foxo1 to alleviate liver injury in graft-versus-host disease mice
Yaxuan Zhao, Zhenghua Chen, Yunhua Wu, Jiashen Zhang, Hengchao Zhang, Kaiyue Han, Hua Wang, Heng Li, Xiying Luan
International Immunopharmacology.2024; 138: 112554. CrossRef Role of gut/liver metabolites and gut microbiota in liver fibrosis caused by cholestasis
Xing-Ming Xie, Shu Feng, Tao Liu, Jun Feng, Yuan Xu, Zi-Jun Fan, Guo-Ying Wang
International Immunopharmacology.2024; 139: 112747. CrossRef Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier
Linzhang Zhang, Xiaoyu Jiang, Jiewen Shi, Jianwei Zhang, Xiaoli Shi, Zhishen Xie, Gaofeng Chen, Hua Zhang, Yongping Mu, Jiamei Chen, Shenglan Qi, Ping Liu, Wei Liu
Journal of Ethnopharmacology.2024; 335: 118649. CrossRef Dysregulation of sphingolipid metabolism in liver fibrosis
Nan Wu, Meiyi Song, Fan Zhang, Sayed Obaidullah Aseem, Phillip B. Hylemon, Huiping Zhou
Metabolism and Target Organ Damage.2024;[Epub] CrossRef Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
Zhen Xun, Xiaobao Yao, Qishui Ou
Cellular & Molecular Immunology.2023; 20(9): 1087. CrossRef Treatment of liver fibrosis: Past, current, and future
Chun-Ye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology.2023; 15(6): 755. CrossRef JTE-013 Alleviates Pulmonary Fibrosis by Affecting the RhoA/YAP Pathway and Mitochondrial Fusion/Fission
Jiaxu Zhou, Yilan Song, Xingmei Wang, Xinrui Li, Chang Liu, Chenchen Tian, Chongyang Wang, Liangchang Li, Guanghai Yan, Hong Cui
Pharmaceuticals.2023; 16(10): 1444. CrossRef
|